Home > News > Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures in Cancer Patients
Supportive Cancer Care
Read Time: 2 mins

Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures in Cancer Patients

Published Online: May 15th 2012 European Oncology & Haematology, 2012;8(3):144-7 DOI: https://doi.org/10.17925/EOH.2012.08.3.144
Authors: Leonard Bastian
Quick Links:
Abstract
Article
Article Information
Abstract:
Overview

Patients with cancer are at increased risk of painful vertebral compression fractures (VCFs). The Cancer Patient Fracture Evaluation (CAFE) trial was the first randomised controlled study to compare the safety and effectiveness of balloon kyphoplasty (BKP – a minimally invasive procedure) with non-surgical fracture management in the treatment of VCFs in patients with cancer. Data from the CAFE trial demonstrated that BKP is a safe and effective treatment option that quickly reduces pain and improves physical function and vertebral body height in patients with cancer and painful VCFs. Data from peer-reviewed published studies support the CAFE trial findings.

Keywords

Balloon kyphoplasty, vertebral compression fracture, cancer, safety, effectiveness, pain, risk

Article:

Patients with cancer are at increased risk of painful vertebral compression fractures (VCFs), loss of mobility, neurological deficits and reduced quality of life (QoL).1,2 VCFs can occur as a direct consequence of cancer or as an indirect consequence of the cancer therapy and are prevalent in patients with multiple myeloma or secondary metastases (in particular from breast and prostate carcinoma).3 Indeed, the risk of developing a VCF is five times higher in women with breast cancer than in women without breast cancer.4 Furthermore, the presence of one VCF is frequently associated with an increased risk of future vertebral fractures5 that can lead to further deteriorations in health and wellbeing. Thus, the long-term consequences of VCFs include progressive spinal deformity and pain as well as substantial impairments in physical, psychological and social functioning.6

Painful VCFs are usually treated using either non-surgical management or surgical methods. The aims of non-surgical management, which uses analgesics, bed rest, radiation therapy and antiresorptive therapy, are to reduce pain, improve functional status and prevent future fractures.7 However, non-surgical management often proves to be of limited effectiveness. Furthermore, as patients with VCFs often have poor bone quality, conventional open surgery may not always be the optimum treatment choice and is normally reserved for individuals with neurological impairment.8 Balloon kyphoplasty (BKP) represents a minimally invasive surgical treatment option.

About Balloon Kyphoplasty
BKP involves percutaneous augmentation of the fractured vertebra by orthopaedic balloon dilation and injection of bone cement under low manual pressure. It is a minimally invasive procedure that has been used worldwide to treat over one million patients with VCFs in all indications. It aims to restore the anatomic shape of the vertebral body, decrease spinal deformity, reduce pain and improve physical function. The procedure usually takes less than one hour per fracture level and requires little or no post-operative rehabilitation. The different steps of a BKP procedure are shown in Figure 1. More information about BKP can be found on the Medtronic website.9

To view the full article in PDF or eBook formats, please click on the icons above.

Article Information:
Disclosure

Leonard Bastian has received honoraria for consulting for Medtronic Spine LLC.

Correspondence

Leonard Bastian, Direktor, Klinik für Orthopädie, Unfall-, Hand- und Wiederherstellungschirurgie, Klinikum Leverkusen GmbH, Am Gesundheitspark 11, 51375 Leverkusen, Germany. E: leonard.bastian@klinikum-lev.de

Support

The publication of this article was funded by Medtronic Inc. The views and opinions expressed are those of the author and not necessarily those of Medtronic Inc.

Received

2012-04-19T00:00:00

References

  1. Roodman GD, Pathogenesis of myeloma bone disease, Blood Cells Mol Dis, 2004;32:290–2.
  2. Guise TA, Mundy GR, Cancer and bone, Endocr Rev, 1998;19:18–54.
  3. Coleman RE, Skeletal complications of malignancy, Cancer, 1997;80(8 Suppl.):1588–94.
  4. Alberico RA, Balloon kyphoplasty for multilevel spinal metastases from breast cancer, J Support Oncol, 2007;5:243–6.
  5. Lindsay R, Silverman SL, Cooper C, et al., Risk of new vertebral fracture in the year following a fracture, JAMA, 2001;285:320–3.
  6. Gold DT, Silverman SL, The Downward Spiral of Vertebral Osteoporosis: Consequences, Cedars-Sinai Medical Center, 2003.
  7. Berenson J, Pflugmacher R, Jarzem P, et al., Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial, Lancet Oncol, 2011;12:225–35.
  8. Wardlaw D, Cummings SR, Van Meirhaeghe J, et al., Efficacy and safety of balloon kyphoplasty compared with nonsurgical care for vertebral compression fracture (FREE): a randomised controlled trial, Lancet, 2009;373:1016–24.
  9. Available at: www.medtronic.co.uk/your-health/spinalfractures/ device/what-is-it/index.htm (accessed 09 May 2012).
  10. Ashamalla H, Cardoso E, Macedon M, et al., Phase I trial of vertebral intracavitary cement and samarium (VICS): novel technique for treatment of painful vertebral metastasis, Int J Radiat Oncol Biol Phys, 2009;75:836–42.
  11. Astolfi S, Scaramuzzo L, Logroscino CA, A minimally invasive surgical treatment possibility of osteolytic vertebral collapse in multiple myeloma, Eur Spine J, 2009;18(Suppl. 1):115–21.
  12. Cardoso ER, Ashamalla H, Weng L, et al., Percutaneous tumor curettage and interstitial delivery of samarium-153 coupled with kyphoplasty for treatment of vertebral metastases, J Neurosurg Spine, 2009;10:336–42.
  13. Dalbayrak S, Onen MR, Yilmaz M, Naderi S, Clinical and radiographic results of balloon kyphoplasty for treatment of vertebral body metastases and multiple myelomas, J Clin Neurosci, 2010;17:219–24.
  14. Dudeney S, Lieberman IH, Reinhardt MK, Hussein M, Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma, J Clin Oncol, 2002;20:2382–7.
  15. Eleraky M, Papanastassiou I, Setzer M, et al., Balloon kyphoplasty in the treatment of metastatic tumors of the upper thoracic spine, J Neurosurg Spine, 2011;14:372–6.
  16. Fourney DR, Schomer DF, Nader R, et al., Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients, J Neurosurg, 2003; 98(Suppl. 1):21–30.
  17. Gerszten PC, Germanwala A, Burton SA, et al., Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures, J Neurosurg Spine, 2005;3:296–301.
  18. Gerszten PC, Monaco EA 3rd, Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique, Neurosurg Focus, 2009;27:E9.
  19. Huber FX, McArthur N, Tanner M, et al., Kyphoplasty for patients with multiple myeloma is a safe surgical procedure: results from a large patient cohort, Clin Lymphoma Myeloma, 2009;9:375–80.
  20. Khanna AJ, Reinhardt MK, Togawa D, Lieberman IH, Functional outcomes of kyphoplasty for the treatment of osteoporotic and osteolytic vertebral compression fractures, Osteoporos Int, 2006;17:817–26.
  21. Köse KC, Cebesoy O, Akan B, et al., Functional results of vertebral augmentation techniques in pathological vertebral fractures of myelomatous patients, J Natl Med Assoc, 2006;98:1654–8.
  22. Lane JM, Hong R, Koob J, et al., Kyphoplasty enhances function and structural alignment in multiple myeloma, Clin Orthop Relat Res, 2004;Sep:49–53.
  23. Lieberman I, Reinhardt MK, Vertebroplasty and kyphoplasty for osteolytic vertebral collapse, Clin Orthop Relat Res, 2003;(415 Suppl.):S176–86.
  24. Pflugmacher R, Schulz A, Schroeder RJ, et al, [A prospective two-year follow-up of thoracic and lumbar osteolytic vertebral fractures caused by multiple myeloma treated with balloon kyphoplasty], Z Orthop Ihre Grenzgeb, 2007;145:39–47.
  25. Pflugmacher R, Taylor R, Agarwal A, et al., Balloon kyphoplasty in the treatment of metastatic disease of the spine: a 2-year prospective evaluation, Eur Spine J, 2008;17:1042–8.
  26. Qian Z, Sun Z, Yang H, et al., Kyphoplasty for the treatment of malignant vertebral compression fractures caused by metastases, J Clin Neurosci, 2011;18:763–7.
  27. Sandri A, Carbognin G, Regis D, et al., Combined radiofrequency and kyphoplasty in painful osteolytic metastases to vertebral bodies, Radiol Med, 2010;115:261–71.
  28. Vrionis FD, Hamm A, Stanton N, et al., Kyphoplasty for tumor-associated spinal fractures, Tech Reg Anesth Pain Manag, 2005;9:35–9.
  29. Zhao J, Lin EH, Wu BL, Acrylic resin bone cement injection following percutaneous kyphoplasty to reconstruct spinal stability, J Clin Rehabil Tissue Eng Res, 2008;36:7089–92.
  30. Zou J, Mei X, Gan M, Yang H, Kyphoplasty for spinal fractures from multiple myeloma, J Surg Oncol, 2010;102:43–7.

Further Resources

Share this Article
Related Content In Supportive Cancer Care
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72